Image

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to learn about the risk factors and prediction of postoperative venous thromboembolism (VTE) in patients undergoing lung cancer surgery. The main question it aims to answer is:

Which clinical, surgical, and laboratory factors are associated with the development of postoperative deep vein thrombosis (DVT) in lung cancer surgery patients, and can machine learning models accurately predict individual risk?

Participants undergoing lung cancer surgery will be prospectively followed for 30 days after surgery. Perioperative clinical data, laboratory results, and imaging findings will be collected to identify VTE risk factors and to develop a predictive model.

Eligibility

Inclusion Criteria:

  1. Age ≥ 18 years
  2. Patients undergoing surgical resection for lung cancer
  3. Postoperative hospital stay ≥ 48 hours
  4. Availability of perioperative clinical, laboratory, and imaging data
  5. Willingness to provide informed consent and participate in 30-day follow-up

Exclusion Criteria:

  1. Pre-existing deep vein thrombosis (DVT) or pulmonary embolism (PE) before surgery
  2. Preoperative or ongoing anticoagulation therapy for ≥ 2 weeks
  3. Severe coagulation disorders or bleeding diseases
  4. Severe hepatic, renal, or hematologic dysfunction, or uncontrolled systemic infection
  5. Concurrent major organ surgery (e.g., cardiac, liver surgery)
  6. Pregnancy or lactation
  7. Incomplete postoperative follow-up data

Study details
    Lung Cancer (Diagnosis)
    Deep Vein Thrombosis (DVT)
    Venous Thromboembolism (VTE)

NCT07439991

The First Hospital of Jilin University

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.